R

Retina Associates of Kentucky | Lexington, KY

Research site
(Unclaimed)
Location
120 North Eagle Creek Drive, Suite 500, Lexington, Kentucky, United States of America
Site insights

Top conditions

Macular Degeneration (18 trials)

Macular Edema (7 trials)

Edema (6 trials)

Wet Macular Degeneration (5 trials)

Geographic Atrophy (3 trials)

Top treatments

Ranibizumab
KSI-301
Aflibercept
ranibizumab
bevacizumab
Faricimab
Lampalizumab
aflibercept
DHA
EPA

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 29
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study Assessing Corneal Endothelial Cells in Patients With Neovascular Age-related Macular Degeneration Treated With the Port Delivery System With Ranibizumab (PDS) (Belvedere)

This study will assess corneal endothelial cells in patients with neovascular age-related macular degeneration (nAMD) treated with Port Delivery Syst...

Enrolling
Neovascular Age-related Macular Degeneration
Drug: LUCENTIS (ranibizumab injection)
Device: SUSVIMO Port Delivery System with ranibizumab (PDS)
Locations recently updated

This study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in patients with neovas...

Enrolling
Neovascular Age-Related Macular Degeneration
Drug: PDS Implant with Ranibizumab 100 mg/mL

This study will evaluate the efficacy, safety, and pharmacokinetics of the Port Delivery System with Ranibizumab (PDS) in Participants with Diabetic...

Active, not recruiting
Diabetic Macular Edema
Drug: Intravitreal Ranibizumab 0.5 mg Injection
Drug: PDS Implant Pre-Filled with 100 mg/mL Ranibizumab

Trial sponsors

Roche logo

Roche (9 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems